Scienture Holdings, Inc. announced a securities purchase agreement with institutional investors.
The agreement involves the purchase of 3,225,000 shares of common stock at $1.20 per share.
The gross proceeds from the offering are expected to be approximately $3.9 million.
Securities Purchase Agreement
Entered into an agreement with institutional investors for the purchase of 3,225,000 shares.
Offering Price
Priced at $1.20 per share, expecting gross proceeds of $3.9 million.
Closing Date
The offering is set to close on August 15, 2025, subject to customary conditions.
- The offering is part of Scienture's strategy to raise capital for future growth and expansion.
- This agreement demonstrates investor confidence in Scienture's business and potential.
The securities purchase agreement marks a significant milestone for Scienture Holdings, providing a boost in capital for its pharmaceutical operations.